How to make sure you get a quality gynecologic cancer treatment

The American Cancer Society is calling for doctors to use “evidence-based practices” in their diagnoses of cervical cancer.

The society’s guidelines for diagnosing cervical cancer were published in May, but many physicians have not followed them.

“As a nation, we have a lot of physicians who are just doing what’s done before,” said Dr. J. Michael Pearson, chief medical officer of the American Cancer Association.

“I think the American College of Surgeons has been a leader in this.

They have been advocating for evidence-based approaches for decades.”

The American College says its members are “not only physicians but also other health professionals, from health care practitioners, to the medical profession and the public health community.”

“The American Cancer Agency has been an important force in developing these guidelines,” said Pearson.

“We’ve always said, we need to get the right diagnosis and treatment, but we’re not just looking at this from the outside looking in.

We need to look at what is being done to support that diagnosis.”

Dr. Thomas J. Pang, professor of gynecologist-at-large at the University of California, San Francisco, and one of the authors of the guidelines, said the association believes that doctors should not treat the cancer at all unless they are certain that there is an absolute certainty that there will be no side effects.

“In other words, doctors should be very cautious about prescribing medication,” Pang said.

“But the bottom line is we should know the risks of this medicine.

And we should be absolutely certain.”

There are several different types of cervical cancers, including a non-melanoma skin cancer, a melanoma, a papilloma, and a basal cell carcinoma.

Cervical cancer is a very aggressive cancer that often leads to a life-threatening disease.

Pumps, lasers, and other forms of treatment are available for certain types of cancer, and many doctors are seeing fewer and fewer of the aggressive cancer types in their patients.

“It’s not a question of if we will see any of these cancer types, it’s a question when,” said Pang.

“There’s not going to be any time to wait.

We have to get this right.”

This article originally appeared on